Toshiba Stroke & Vascular Research Center
Given its complex nature, stroke therapy research demands a truly multidisciplinary approach.
Recognizing this need for collaboration in stroke research, UBNS chairman and pioneering neurosurgeon, L.N. Hopkins, M.D., co-founded University at Buffalo's Toshiba Stroke & Vascular Research Center in 1997.
Today, the center still stands as a quintessential example of multidisciplinary cooperation and partnership. Within the facility, basic science as well as diverse clinical specialties, including radiation physics, biomedical and aerospace engineering, polymer chemistry, neuroradiology, neurology, and neurosurgery, all contribute to the advancement of knowledge in the field of stroke prevention and treatment.
Researchers at the center focus on three major areas of inquiry: image optimization and dose reduction, hemodynamics (to better understand the physiological mechanisms that produce brain aneurysms), and device development. The research team, composed of an eclectic mix of investigators representing diverse yet complementary areas of expertise, including UBNS neurosurgeons, has created the synergy necessary to advance the art and science of minimally invasive endovascular therapy into the next century. Further, the center has formed strategic alliances with local, national, and international industry partners to advance its research goals.
In the twelve years of its existence, the Toshiba Stroke & Vascular Research Center has produced significant advances in all three of its main areas of research, with progress in one area opening new possibilities for research in the other areas: improved imaging reveals potential new avenues for device design; new devices present new opportunities for hemodynamic investigation; and clinical experience informs the direction of research in all three.
In addition to funding from the Toshiba Corporation, research at the center has been supported by significant grants from the National Institute of Neurological Disorders and Stroke; the National Heart, Lung, and Blood Institute; the National Institute of Biomedical Imaging and Bioengineering; and the National Science Foundation.